<?xml version="1.0" encoding="UTF-8"?>
<ref id="pntd.0006934.ref065">
 <label>65</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Smit</surname>
   <given-names>MR</given-names>
  </name>, 
  <name>
   <surname>Ochomo</surname>
   <given-names>EO</given-names>
  </name>, 
  <name>
   <surname>Aljayyoussi</surname>
   <given-names>G</given-names>
  </name>, 
  <name>
   <surname>Kwambai</surname>
   <given-names>TK</given-names>
  </name>, 
  <name>
   <surname>Abong'o</surname>
   <given-names>BO</given-names>
  </name>, 
  <name>
   <surname>Chen</surname>
   <given-names>T</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial</article-title>. 
  <source>The Lancet Infectious Diseases</source>. 
  <year>2018</year>;
  <volume>18</volume>(
  <issue>6</issue>):
  <fpage>615</fpage>â€“
  <lpage>26</lpage>. 
  <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S1473-3099(18)30163-4" xmlns:xlink="http://www.w3.org/1999/xlink">10.1016/S1473-3099(18)30163-4</ext-link>
  <?supplied-pmid 29602751?>
  <pub-id pub-id-type="pmid">29602751</pub-id>
 </mixed-citation>
</ref>
